Clinical Trial Results:
Effect on glycaemic control of liraglutide or exenatide added to metformin, sulphonylurea or a combination of both in subjects with type 2 diabetes
A 26-week randomised, open-label, active comparator, 2-armed, parallel-group, multi-centre, multi-national trial with a 14 week non-randomised extension period followed by an additional 38-week, non-randomised extension period
Summary
|
|
EudraCT number |
2006-006092-21 |
Trial protocol |
SE IE FI DE ES DK SI FR PL AT |
Global completion date |
14 Apr 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
25 Feb 2016
|
First version publication date |
16 Jul 2014
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
Synopsis Synopsis Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.